- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 3 x NAG- NAG- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 3 residues within 4Å:- Chain A: I.145, K.164, N.188
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 1 residues within 4Å:- Chain A: N.335
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 5 residues within 4Å:- Chain A: D.326, N.355, T.358, S.610, L.662
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.610
NAG-NAG.5: 2 residues within 4Å:- Chain A: L.662, N.664
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 3 residues within 4Å:- Chain B: H.142, K.186, N.188
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 1 residues within 4Å:- Chain B: N.335
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 4 residues within 4Å:- Chain B: N.355, T.358, N.605, L.662
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:L.662
NAG-NAG.10: 2 residues within 4Å:- Chain B: L.662, N.664
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 4 residues within 4Å:- Chain C: H.142, E.147, K.186, N.188
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 1 residues within 4Å:- Chain C: N.335
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain C: D.326, N.355, T.358, N.605
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 3 residues within 4Å:- Chain C: L.662, T.663, N.664
No protein-ligand interaction detected (PLIP)- 51 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 2 residues within 4Å:- Chain A: N.19, N.22
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: Y.28, N.29, K.30, T.31
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.58, E.272
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: V.113, N.114
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: I.169, N.171
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: N.192, S.194, A.195, V.216
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: S.247, N.251
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.433
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.454
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: Q.683, N.684
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: G.617, V.618, N.703
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: F.713, D.714, N.725, T.727
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.771
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.776
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: T.792, N.793
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: E.920, N.924, S.929
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: V.1210, N.1211
- Chain B: D.880
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain B: N.19, N.22
- Ligands: NAG-NAG-MAN-MAN-MAN-MAN.6
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.29
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.58
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: V.113, N.114, Y.118
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: I.169, N.171
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: N.192, S.194, A.195
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: D.250, N.251
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain B: N.433
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain B: N.454
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.684
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: G.617, N.702, N.703
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: D.714, N.725, T.727
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.771
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.776
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.793
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain B: E.920, A.921, N.924, S.929
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain B: N.1211
- Chain C: D.880, N.881, Q.1001
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: N.19, N.22
- Ligands: NAG-NAG-MAN-MAN-MAN-MAN.11
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: N.29, K.30, T.31
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.58
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: V.113, N.114
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: I.169, N.171
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain C: N.192, S.194, A.195
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: S.247, N.251
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.433
Ligand excluded by PLIPNAG.58: 1 residues within 4Å:- Chain C: N.454
Ligand excluded by PLIPNAG.59: 1 residues within 4Å:- Chain C: N.684
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain C: G.617, N.702, N.703
Ligand excluded by PLIPNAG.61: 4 residues within 4Å:- Chain C: D.714, N.725, T.727, S.728
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Chain C: N.771
Ligand excluded by PLIPNAG.63: 1 residues within 4Å:- Chain C: N.776
Ligand excluded by PLIPNAG.64: 1 residues within 4Å:- Chain C: N.793
Ligand excluded by PLIPNAG.65: 4 residues within 4Å:- Chain C: E.920, A.921, N.924, S.929
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain A: D.880, Q.1001
- Chain C: N.1211
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xia, L. et al., Structural basis for the recognition of HCoV-HKU1 by human TMPRSS2. Cell Res. (2024)
- Release Date
- 2024-05-01
- Peptides
- Spike glycoprotein: ABC
Transmembrane protease serine 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 3 x NAG- NAG- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 51 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xia, L. et al., Structural basis for the recognition of HCoV-HKU1 by human TMPRSS2. Cell Res. (2024)
- Release Date
- 2024-05-01
- Peptides
- Spike glycoprotein: ABC
Transmembrane protease serine 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E